Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised ProcessUnity, and Cooley advised CyberGRX on the deal. ProcessUnity and CyberGRX announced that the Third-Party Risk Management (TPRM) leaders have joined forces,...
You must be a Standard 1 Year member to access this content.
Cooley advises ThoughtSpot on the deal. ThoughtSpot announced it has signed a definitive agreement to acquire Mode Analytics in a cash and equity deal valued at $200...
You must be a Standard 1 Year member to access this content.
Cooley is acting as legal counsel to Veritone, and Sidley Austin is acting as legal counsel to Career Builder. Veritone, Inc. (NASDAQ: VERI) announced its agreement...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Cooley advised 1Life Healthcare Inc., which operates under the name One Medical, on the deal, while Crowell & Moring and Paul, Weiss,...
You must be a Standard 1 Year member to access this content.
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
You must be a Standard 1 Year member to access this content.
Cooley advised Carpe Data on the deal. Carpe Data, a provider of innovative emerging and alternative data products for the insurance industry, announced its strategic growth investment...
You must be a Standard 1 Year member to access this content.
Cooley advised Snyk on the deal. Snyk, a leader in developer security, announced its acquisition of Fugue, a cloud security and compliance company. This milestone marks Snyk’s...
You must be a Standard 1 Year member to access this content.
